Methylene Blue for Skin Cancer Not Removable by Surgery
Part of Cancer clinical trials.
This trial tests a new methylene blue formula injected into skin cancer tumors that cannot be removed by surgery or treated with radiation. It is for people who have one or more small tumors (each less than 2 cm) and cannot have the usual treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed squamous cell carcinoma skin cancer (proven by a biopsy).
- You are not able to have surgery or radiation for your cancer, or you cannot use other injected treatments like interferon or 5-FU.
- You have one or more skin tumors that are each smaller than 2 cm (about the size of a pea).
- You are 18 years or older.
- You do not have heart disease, blood clots, bleeding disorders, or an allergy to methylene blue.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a methylene blue gel for people with certain types of basal cell carcinoma (a common skin cancer) who cannot have surgery or radiation. The goal is to see if the gel can treat the cancer safely and effectively.
This trial tests if methylene blue can help people who develop side effects called CRS or ICANS after treatments like CAR-T cells or bispecific antibodies. It is a first-in-human study to find a safe dose.
This study tests a light-activated treatment (photodynamic therapy) for a very early form of skin cancer on the face. It may offer an alternative to surgery.
This trial tests whether a blue dye (methylene blue) applied directly to burn wounds and activated with light can help fight infection. It's designed for people with moderate to deep burns that will require several dressing changes.
This early-phase study tests whether delivering chemotherapy through tiny skin needles (microneedles) can shrink or control cutaneous squamous cell cancer (cSCC) that can be surgically treated. Because it’s Phase 1/2, the main goals are to check safety and find the best way to deliver the treatment.
This trial tests a device placed on skin cancer lesions to see which drugs might work best. It is for people with visible squamous cell carcinoma on the skin, including lesions that have come back after radiation.
Hear when a new Inoperable Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.